Michael Sofia
2023
In 2023, Michael Sofia earned a total compensation of $1.6M as Chief Scientific Officer at Arbutus Biopharma Corp, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $147,600 |
|---|---|
| Option Awards | $720,208 |
| Salary | $492,000 |
| Stock Awards | $238,380 |
| Other | $16,500 |
| Total | $1,614,688 |
Sofia received $720.2K in option awards, accounting for 45% of the total pay in 2023.
Sofia also received $147.6K in non-equity incentive plan, $492K in salary, $238.4K in stock awards and $16.5K in other compensation.
Rankings
In 2023, Michael Sofia's compensation ranked 705th out of 2,790 executives tracked by ExecPay. In other words, Sofia earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 705 out of 2,790 | 75th |
Division Manufacturing | 407 out of 1,530 | 73rd |
Major group Chemicals And Allied Products | 278 out of 869 | 68th |
Industry group Drugs | 272 out of 832 | 67th |
Industry Pharmaceutical Preparations | 178 out of 597 | 70th |
Source: SEC filing on April 10, 2024.
Sofia's colleagues
We found three more compensation records of executives who worked with Michael Sofia at Arbutus Biopharma Corp in 2023.
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020